Slow Uptake of an Effective Therapy: Patterns of Olanzapine Prescribing for Those Receiving Highly Emetogenic Chemotherapy.
Daniel S ChildsDavid A HelfinstineLindsey SangaralinghamJacob J OrmeCiara Catherine O'SullivanCharles L LoprinziKathryn J RuddyPublished in: JCO oncology practice (2022)
Despite inclusion in major antiemesis guidelines, there has been relatively slow uptake of olanzapine for prophylaxis with HEC. This finding highlights the challenges of disseminating information and keeping prescribing systems updated with the newest evidence in supportive oncology.